Verizon Business CEO Grows Stake to 381,888 Units Through Executive Compensation

Rhea-AI Filing Summary

Verizon Communications (VZ) EVP and Group CEO-VZ Business Kyle Malady reported a transaction of phantom stock units on June 18, 2025. The insider acquired 145.529 phantom stock units at $11.89 per unit through the company's Deferred Compensation Plan.

Key transaction details:

• The phantom stock is economically equivalent to a portion of one common stock share but settles in cash
• The total beneficial ownership following the transaction is 381,888.143 units, held indirectly through the Deferred Compensation Plan
• The reported amount includes phantom stock acquired through dividend reinvestment
• Payment timing is based on events established by the reporting person under the deferred compensation plan terms

The Form 4 was filed by attorney-in-fact Evgeniya Berezkina on June 20, 2025, within the required reporting window.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Malady Kyle

(Last) (First) (Middle)

VERIZON COMMUNICATIONS INC.

1095 AVENUE OF THE AMERICAS

(Street)

NEW YORK NY 10036

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
VERIZON COMMUNICATIONS INC [ VZ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP and Group CEO-VZ Business

3. Date of Earliest Transaction (Month/Day/Year)
06/18/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Phantom Stock (unitized)	(1)	06/18/2025		A		145.529		(1)	(1)	Common Stock	42	$11.89	381,888.143(2)	I	By Deferred Compensation Plan

Explanation of Responses:

1. Each share of phantom stock is the economic equivalent of a portion of one share of common stock and is settled in cash. The shares of phantom stock become payable upon events established by the reporting person in accordance with the deferred compensation plan.

2. Includes phantom stock acquired through dividend reinvestment.

	Evgeniya Berezkina, Attorney-in-fact for Kyle Malady	06/20/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did VZ EVP Kyle Malady report on June 18, 2025?

Kyle Malady, EVP and Group CEO of VZ Business, acquired 145.529 units of phantom stock through Verizon's Deferred Compensation Plan at a price of $11.89 per unit. The phantom stock is economically equivalent to 42 shares of common stock and will be settled in cash.

How many phantom stock units does Kyle Malady own in VZ after the June 2025 transaction?

Following the reported transaction, Kyle Malady beneficially owns 381,888.143 units of phantom stock through Verizon's Deferred Compensation Plan, which includes units acquired through dividend reinvestment.

What is the settlement structure for VZ's phantom stock units reported in the Form 4?

According to the filing, each phantom stock unit is the economic equivalent of a portion of one share of common stock and is settled in cash. The payment timing is determined by events established by the reporting person (Kyle Malady) in accordance with the deferred compensation plan.

Who filed the Form 4 for VZ's Kyle Malady?

The Form 4 was filed by Evgeniya Berezkina, serving as Attorney-in-fact for Kyle Malady, and was signed on June 20, 2025.